Search research articles
Contact Us
Filters
Showing results (1-10 of 90) with videos related to
Page
of 9
Sort By:
Cancer
|
July 15, 1986
The use of prognostic factors in clinical trials
H N Sather
Medical and Pediatric Oncology
|
January 1, 1986
Statistical evaluation of prognostic factors in ALL and treatment results
H N Sather
Medical and Pediatric Oncology
|
January 1, 1986
Age at diagnosis in childhood acute lymphoblastic leukemia
H N Sather
Journal of Chronic Diseases
|
January 1, 1985
Determining the duration of comparative clinical trials while allowing for cure
R Sposto, H N Sather
Biometrics
|
June 1, 1995
Group sequential methods for comparison of cure rates in clinical trials
J W Lee, H N Sather
Biometrics
|
March 1, 1992
A comparison of tests of the difference in the proportion of patients who are cured
R Sposto, H N Sather, S A Baker
Medical and Pediatric Oncology
|
February 25, 1998
High-dose cytosine arabinoside and L-asparaginase in refractory acute lymphoblastic leukemia: the Children's Cancer Group experience
R E Harris, H N Sather, S A Feig
Controlled Clinical Trials
|
December 1, 1994
Power considerations for testing an interaction in a 2 x k factorial design with a failure time outcome
A H Xiang, H N Sather, S P Azen
Medical and Pediatric Oncology
|
October 23, 1997
Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: a study of the Children's Cancer Group (CCG-1884)
S A Feig, R E Harris, H N Sather
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 1, 1991
Evaluation of the Shimada classification in advanced neuroblastoma with a special reference to the mitosis-karyorrhexis index: a report from the Childrens Cancer Study Group
V V Joshi, J Chatten, H N Sather, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 90) with videos related to
Sort By:
Page
of 9
Cancer
|
July 15, 1986
The use of prognostic factors in clinical trials
H N Sather
Medical and Pediatric Oncology
|
January 1, 1986
Statistical evaluation of prognostic factors in ALL and treatment results
H N Sather
Medical and Pediatric Oncology
|
January 1, 1986
Age at diagnosis in childhood acute lymphoblastic leukemia
H N Sather
Journal of Chronic Diseases
|
January 1, 1985
Determining the duration of comparative clinical trials while allowing for cure
R Sposto, H N Sather
Biometrics
|
June 1, 1995
Group sequential methods for comparison of cure rates in clinical trials
J W Lee, H N Sather
Biometrics
|
March 1, 1992
A comparison of tests of the difference in the proportion of patients who are cured
R Sposto, H N Sather, S A Baker
Medical and Pediatric Oncology
|
February 25, 1998
High-dose cytosine arabinoside and L-asparaginase in refractory acute lymphoblastic leukemia: the Children's Cancer Group experience
R E Harris, H N Sather, S A Feig
Controlled Clinical Trials
|
December 1, 1994
Power considerations for testing an interaction in a 2 x k factorial design with a failure time outcome
A H Xiang, H N Sather, S P Azen
Medical and Pediatric Oncology
|
October 23, 1997
Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: a study of the Children's Cancer Group (CCG-1884)
S A Feig, R E Harris, H N Sather
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 1, 1991
Evaluation of the Shimada classification in advanced neuroblastoma with a special reference to the mitosis-karyorrhexis index: a report from the Childrens Cancer Study Group
V V Joshi, J Chatten, H N Sather, et al.
Page
of 9